로딩 중…
지수 로딩 중…
Pharmicell Co.,Ltd.
005690· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩13,450-5.61%
2026-06-19
Price Chart
Pharmicell Co.,Ltd.+20.74%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 807.05B KRW |
| Revenue | 123.72B KRW |
| Net Income | 43.54B KRW |
| Total Assets | 168.10B KRW |
| Net Assets | 132.78B KRW |
| Employees | 146 |
| Value | |
| P/E | 18.54x |
| P/B | 6.08x |
| PEG | 0.48x |
| P/S | 6.52x |
| EV/EBITDA | 56.17x |
| FCF Yield | 4.16% |
| Profitability | |
| ROE | 32.79% |
| ROA | 25.90% |
| Op. Margin | 31.52% |
| Revenue Growth | 35.75% |
| Earnings Growth | 38.44% |
| Financial Health | |
| Debt Ratio | 126.60% |
| Total Debt | 19.94B KRW |
| FCF | 33.60B KRW |
| Cash | 22.88B KRW |
| Current Ratio | 6.86x |
| Net Debt/EBITDA | -0.21x |
| Dividend | |
| Div. Yield | 0.35% |
| Div. Growth | 150.00% |
| Performance | |
| 1Y Return | 20.74% |
| 1M Return | -11.10% |
| From 52W High | -36.41% |
| 1Y MDD | -40.54% |
| Trading | |
| Volume | 764,635 shares |
| Foreign Own. | 11.02% |
| Per Share | |
| EPS | 725 KRW |
| BPS | 2,213 KRW |
Company Info
Pharmicell, established in 1968 and renamed in 2011, is a specialized biotech company listed in 1988. It operates a biomedical division, manufacturing and selling the world's first stem cell therapy, and a biochemical division, producing pharmaceutical intermediates and eco-friendly phosphorus flame retardants, in addition to stem cell banking and cosmetics businesses. The company has developed and patented technologies for anticancer immunotherapy dendritic cells and neurological disorder treatments. Pharmicell is actively pursuing innovation through technology development in areas such as mRNA vaccine raw materials and artificial blood, and is headquartered in Gangnam-gu, Seoul.